Q4 2024 Earnings Call Transcript March 3, 2025 Fractyl Health, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.52 EPS, expectations were $-0.44. Operator: Good afternoon, and ...
Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ETCompany ParticipantsBrian Luque – Head of Investor Relations ...
Sooma announced that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation ...
Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...
DURHAM, N.C., March 4, 2025 /PRNewswire/ -- Levee Medical is pleased to announce that the U.S. Food and Drug Administration ... Device Exemption (IDE). ARID II is a multicenter, single blind ...
Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency ("RF") Generator On track for Investigational Device Exemptio ...
The FDA has given a 27 March 2021 review date for Bristol-Myers Squibb’s multiple myeloma cell therapy ide-cel, just in time to meet a contingent value right (CVR) due to Celgene shareholders if ...
The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback